Editas Medicine (EDIT) Change in Accured Expenses (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Change in Accured Expenses data on file, last reported at -$543000.0 in Q3 2025.

• On a quarterly basis, Change in Accured Expenses fell 153.5% year-over-year to -$543000.0 in Q3 2025; TTM through Sep 2025 was $18.9 million, a 1418.94% increase from a year earlier, with the FY2024 full-year figure at $11.6 million, up 182.52% from the prior year.
• Change in Accured Expenses for Q3 2025 stood at -$543000.0, down from $578000.0 in the prior quarter.
• Over the last five years, Change in Accured Expenses for EDIT reached as high as $17.1 million in Q4 2024 and fell as low as -$9.6 million in Q1 2021.
• Historically, Change in Accured Expenses has averaged $1.5 million across 5 years, with a median of $1.0 million in 2024.
• Across the five-year window, Change in Accured Expenses surged 368.55% in 2023 and tumbled 288.79% in 2024, its largest moves.
• Year by year, Change in Accured Expenses stood at $9.4 million in 2021, then gained by 16.43% to $11.0 million in 2022, then slumped by 62.77% to $4.1 million in 2023, then jumped by 319.01% to $17.1 million in 2024, then plunged by 103.17% to -$543000.0 in 2025.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$543000.0 in Q3 2025, $578000.0 in Q2 2025, and $1.7 million in Q1 2025.